The prevalence of polycystic ovary syndrome (PCOS) in high school students in Rasht in 2009 according to NIH criteria

International Journal of Fertility and Sterility

Volumn 4, Issue 4, 2011, Pages 156-159

  Asgharnia, Maryam ^a   Mirblook, Fariba ^a   Soltani, Mitra Ahmad ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acne; Amenorrhea; Hirsutism; Male pattern baldness; Oligomenorrhea; Polycystic ovary syndrome

Indexed keywords

ACNE; ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; BODY MASS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLLOW UP; HIGH SCHOOL STUDENT; HIRSUTISM; HUMAN; HYPERANDROGENISM; IRAN; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUATION DISORDER; NATIONAL HEALTH ORGANIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PREVALENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 79953268021     PISSN: 2008076X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. st ed. Oxford: Blackwell Scientific; 1992; 377-384.
2. Ojaniemi M, Pugeat M. An adolescent with polycystic ovary syndrome. Eur J Endocrinol. 2006; 155(suppl 1): s149-152.
3. Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR (editors). Polycystic Ovary Syndrome. Oxford: Blackwell Scientific Publications; 1992; 377-384.
4. Hetch R, Rosenfi eld RH, Kim MH, Trendway D. Hirsutism: implications, etiology and management. Am J Obstet Gynecol. 1981; 140(7): 815-830.
5. Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS, Santen RJ. Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab. 1991; 72(6): 1242-1248.
6. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol. 1977; 97(3): 247-254.
7. Solomon CG: The epidemiology of polycystic ovary syndrome. revalence and associated disease risks. Endocrinol Metab Clin North Am. 1999; 28(2): 247-263.
8. Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1): 19-25.
9. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults, National Institutes of Health, National Heart, Lung, and Blood Institute. Obes Res. 1998; 6 Suppl 2: S51-S209.
10. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM. Standandized percentile curves of body-mass index for children and adolescents. Am J Dis Child.1991; 145(3): 259-263.
11. Sperroff L, Frit MA. Clinical gynecology endocrinology & Infertility. 7th ed., USA: Lippincott Williams F Wilkins; 2005; 479.
12. Gordon CM. Menstrual disorders in adolescents.Excess androgens and the polycystic ovary syndrome. Pediatr Clin North Am. 1999; 46(3): 519-545.
13. Driscoll DA. Polycystic ovary syndrome in adolescence. Annals of the New York Academy of Sciences. 2003; 997: 49-55.
14. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R.Prevalence of the polycystic ovary syndrome in unselected black, and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab.1998; 83(9): 3078-3082.
15. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab. 1999; 84(11): 4006-4011.
16. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000; 85(7): 2434-2438.
17. Van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, Iuteinzing hormone, androgens, and insulin. Fertil Steril 2000; 74(1): 49-58.
18. Givens JR. Ovarian hyperthecosis. N Engl J Med. 1971; 285(12): 691.
19. Battaglia C, Regnani G, Petraglia F, Primavera MR, Salvatori M, Volpe A. Polycystic ovary syndrome: it is always bilateral? Ultrasound Obstet Gynecol. 1999; 14(3): 183-187.
20. Allen SE, Potter HD, Azziz R. Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women. Fertil Steril. 1997; 67(3): 569-572.
21. Van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents. Hum Reprod. 1999; 14(9): 2223-2229.
22. Franks S. Polycystic ovary syndrome in adolescents. Int J Obes(Lond). 2008; 32(7): 1035-1041.
23. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006; 91(2): 492-497.
24. Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome-a hypothesis. J Endocrinol. 2002; 174(1): 1-5.
25. Franks S, McCarthy MI, Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl. 2006; 29(1): 278-285.